LeonaBio, Inc. Common Stock LONA
$4.82
+10.05%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $17.33
- Implied Upside
- +259.6%
- Price Target Range
- $15.00 – $20.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-19 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $16 → $15 |
| 2026-08-17 | CitizensJason N. Butler |
Maintains | Market outperform | $18 → $17 |
| 2026-07-30 | CitizensJason N. Butler |
Upgrades | Market perform → Market outperform | $18 |
| 2026-05-27 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $20 |
| 2026-02-19 | MizuhoGraig Suvannavejh |
Upgrades | Neutral → Outperform | $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.82
- Market Cap
- $45.41 million
- 52-Week Range
- $2.21 – $14.21
- Average Volume
- 317K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.